Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol
Authors
Keywords
Antipsychotics, Therapeutic drug monitoring, CYP2D6, Genotyping
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 72, Issue 2, Pages 175-184
Publisher
Springer Nature
Online
2015-10-30
DOI
10.1007/s00228-015-1965-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants
- (2015) Vincent Haufroid et al. CLINICAL TOXICOLOGY
- The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients
- (2015) Karen van der Weide et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- CYP3A4*22is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen
- (2015) Marina Venzon Antunes et al. PHARMACOGENOMICS
- Clinical applications of CYP genotyping in psychiatry
- (2014) Edoardo Spina et al. JOURNAL OF NEURAL TRANSMISSION
- High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography–tandem mass spectrometry
- (2013) Lisbeth Patteet et al. CLINICA CHIMICA ACTA
- Applications of CYP450 Testing in the Clinical Setting
- (2013) C. F. Samer et al. Molecular Diagnosis & Therapy
- Therapeutic Drug Monitoring of Common Antipsychotics
- (2012) Lisbeth Patteet et al. THERAPEUTIC DRUG MONITORING
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
- (2011) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
- (2011) C. Hiemke et al. PHARMACOPSYCHIATRY
- Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients
- (2010) Silvana Borges et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetics and Psychoactive Drug Therapy: Ready for the Patient?
- (2010) Werner Steimer THERAPEUTIC DRUG MONITORING
- Impact of CYP2D6 Genotype on Steady-State Serum Concentrations of Risperidone and 9-Hydroxyrisperidone in Patients Using Long-Acting Injectable Risperidone
- (2009) Magnhild Hendset et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active Moiety
- (2008) Arzu Gunes et al. THERAPEUTIC DRUG MONITORING
- Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol
- (2003) Jae-Gook Shin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now